Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal tight junction proteins form a complex, dynamic multi-protein structure at the apical-most region of the epithelial lateral membrane. Their primary role is to seal the paracellular space between intestinal epithelial cells, maintaining the selective permeability barrier that regulates the passage of ions, nutrients, and water, while preventing pathogen and toxin influx. Major components include claudins (the backbone of the seal), occludin, and junctional adhesion molecules (JAMs), each of which links to intracellular scaffolding proteins like zonula occludens (ZO) that connect to the cytoskeleton[1][2][3][4][6][10]. Tight junction protein dysfunction or altered expression is implicated in a broad spectrum of diseases, including intestinal inflammation, infections, and cancer. These proteins are a therapeutic interest both as potential drug targets and as biomarkers for barrier integrity and disease progression. However, since "intestinal tight junction proteins" is a group descriptor, more precise identification of individual members is required for specific drug development or clinical application.
Modulation of tight junction assembly/disassembly; Stabilization or disruption of protein–protein interactions; Regulation of phosphorylation status (notably JAM-A phosphorylation affects permeability); Immunomodulatory effects by modifying barrier antigen flow.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal tight junction protein.